Biomedican successfully biosynthesizes two rare cannabinoids

A California life sciences company named Biomedican is drawing significant attention for the rapid progress it’s made in patented, low-cost methods of biosynthesizing rare cannabinoids. The company uses a proprietary strain of yeast named Yarrowia lipolytica to extract pharmaceutical-grade cannabinoids that are chemically identical to those extracted from cannabis plants. Aside from producing these cannabinoids […]
Biomedican successfully biosynthesizes two rare cannabinoids is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs